PRNewswire/ – The Christopher & Dana Reeve Foundation and Spinal Research have announced $1.5 million in grants to support four preclinical studies focused on developing new treatments for traumatic ...

Market OverviewThe global ostomy devices market is projected to grow at a healthy rate of 4–5% and is expected to reach approximately USD 3.2 billion by 2026. This steady expansion is driven by rising ...

Your urine can tell you a lot about your reproductive health hormones. Unfortunately, at-home testing can be cumbersome, ...

In a significant move aimed at strengthening regulatory clarity for cancer related medical technologies, the Central Drugs ...

In a major shift for how mental health conditions might be treated, the US Food and Drug Administration (FDA) has approved ...

A woman's decades-long struggle with incontinence was finally solved when doctors discovered a rare condition.

Relmada Therapeutics Inc ($RLMD) announced an update on their ongoing clinical study. Relmada Therapeutics is preparing to launch a late-stage ...

Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...

This guide deconstructs the pathophysiology of UTIs, exploring the anatomical risks in women, and the efficacy of antibiotic ...

CHAD Thompson grappled with a silent problem for 20 years – he couldn’t pee properly, and it was a constant source of anxiety ...

While people swear by their favorite home remedies, most—including the three described above—remain unproved. Every now and then, however, a piece of folklore is scientifically validated. Sometimes ...

The first new antibiotic for UTIs in nearly 30 years has been approved by regulators. Gepotidacin, also known as Blujepa, is ...